First Manhattan’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-5,153
Closed -$912K 1533
2020
Q1
$912K Buy
5,153
+111
+2% +$20.9K 0.01% 390
2019
Q4
$963K Sell
5,042
-231
-4% -$41.7K ﹤0.01% 415
2019
Q3
$887K Sell
5,273
-33,108
-86% -$5.39M ﹤0.01% 431
2019
Q2
$6.43M Sell
38,381
-3,834
-9% -$531K 0.04% 204
2019
Q1
$6.18M Sell
42,215
-5,591
-12% -$811K 0.04% 217
2018
Q4
$6.39M Sell
47,806
-78,985
-62% -$12.9M 0.04% 212
2018
Q3
$24.2M Sell
126,791
-1,850
-1% -$340K 0.13% 112
2018
Q2
$21.4M Sell
128,641
-30,270
-19% -$4.86M 0.12% 120
2018
Q1
$26.7M Sell
158,911
-70,584
-31% -$11.8M 0.15% 100
2017
Q4
$37.5M Buy
229,495
+14,322
+7% +$2.57M 0.21% 83
2017
Q3
$44.1M Buy
215,173
+42,210
+24% +$9.82M 0.25% 75
2017
Q2
$42M Buy
172,963
+3,894
+2% +$915K 0.25% 76
2017
Q1
$40.4M Sell
169,069
-662
-0.4% -$154K 0.24% 78
2016
Q4
$35.6M Sell
169,731
-328,062
-66% -$68M 0.22% 89
2016
Q3
$115M Sell
497,793
-196,243
-28% -$48M 0.7% 28
2016
Q2
$160M Buy
694,036
+374,443
+117% +$86.3M 0.99% 20
2016
Q1
$85.7M Sell
319,593
-336,654
-51% -$96.4M 0.53% 36
2015
Q4
$205M Buy
656,247
+270,206
+70% +$80.4M 1.26% 20
2015
Q3
$105M Buy
386,041
+137,501
+55% +$42.2M 0.67% 32
2015
Q2
$75.4M Buy
248,540
+173,317
+230% +$51.7M 0.45% 42
2015
Q1
$22.4M Sell
75,223
-344
-0.5% -$98.1K 0.13% 117
2014
Q4
$19.5M Sell
75,567
-467
-0.6% -$117K 0.11% 124
2014
Q3
$18.3M Buy
76,034
+73,534
+2,941% +$16.5M 0.11% 127
2014
Q2
$557K Hold
2,500
﹤0.01% 493
2014
Q1
$514K Buy
+2,500
New +$495K ﹤0.01% 504
2013
Q4
Sell
-2,500
Closed -$360K 1433
2013
Q3
$360K Hold
2,500
﹤0.01% 550
2013
Q2
$336K Buy
+2,500
New +$283K ﹤0.01% 564

Other funds holding AGN

First Manhattan's AGN Position: Q2 2020 in Review

First Manhattan sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 5,153 shares — an estimated $912K sold.

First Manhattan first reported a position in AGN in Q2 2013 and held it in 27 quarters. The position peaked at $205M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • First Manhattan reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • First Manhattan sold 5,153 Allergan plc shares in Q2 2020, an estimated $912K.
  • First Manhattan first reported a position in Allergan plc in Q2 2013 and held it in 27 quarters.
  • First Manhattan's Allergan plc position peaked at $205M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on First Manhattan's 13F filing for Q2 2020, filed 14 Aug 2020.